157 related articles for article (PubMed ID: 38164181)
1. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF).
Ye X; Tuo Z; Chen K; Wu R; Wang J; Yu Q; Ye L; Miyamoto A; Yoo KH; Zhang C; Wei W; Li D; Feng D
Oncol Res; 2024; 32(3):503-515. PubMed ID: 38361753
[TBL] [Abstract][Full Text] [Related]
3. Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency.
Xu R; Wang Y; Kuang Y
Sci Rep; 2024 Jan; 14(1):1651. PubMed ID: 38238581
[TBL] [Abstract][Full Text] [Related]
4. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling.
Yang Q; Wang M; Xu J; Yu D; Li Y; Chen Y; Zhang X; Zhang J; Gu J; Zhang X
Mol Cancer; 2023 Aug; 22(1):122. PubMed ID: 37537569
[TBL] [Abstract][Full Text] [Related]
5. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.
Wang JZ; Zhu W; Han J; Yang X; Zhou R; Lu HC; Yu H; Yuan WB; Li PC; Tao J; Lu Q; Wei JF; Yang H
Cancer Commun (Lond); 2021 Jul; 41(7):560-575. PubMed ID: 33991457
[TBL] [Abstract][Full Text] [Related]
6. m
Wang N; Chen RX; Deng MH; Wei WS; Zhou ZH; Ning K; Li YH; Li XD; Ye YL; Wen JH; Dong B; Zhang XP; Liu ZW; Zhou FJ
Cell Death Dis; 2023 Feb; 14(2):139. PubMed ID: 36806253
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the role of 5-Methylcytosine RNA methylation in human abdominal aortic aneurysm.
He Y; Zhang H; Yin F; Guo P; Wang S; Wu Y; Xin S; Han Y; Zhang J
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1147-1165. PubMed ID: 34856760
[No Abstract] [Full Text] [Related]
8. ALYREF (Aly/REF export factor): A potential biomarker for predicting cancer occurrence and therapeutic efficacy.
Zhao Y; Xing C; Peng H
Life Sci; 2024 Feb; 338():122372. PubMed ID: 38135116
[TBL] [Abstract][Full Text] [Related]
9. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
Pan W; Liu X; Liu S
Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085
[TBL] [Abstract][Full Text] [Related]
10. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues.
Zhang Q; Zheng Q; Yu X; He Y; Guo W
J Transl Med; 2020 Jun; 18(1):245. PubMed ID: 32571340
[TBL] [Abstract][Full Text] [Related]
11. m
Hu B; Gao J; Shi J; Wen P; Guo W; Zhang S
Mol Carcinog; 2023 Oct; 62(10):1599-1614. PubMed ID: 37449789
[TBL] [Abstract][Full Text] [Related]
12. mRNA m5C controls adipogenesis by promoting CDKN1A mRNA export and translation.
Liu Y; Zhao Y; Wu R; Chen Y; Chen W; Liu Y; Luo Y; Huang C; Zeng B; Liao X; Guo G; Wang Y; Wang X
RNA Biol; 2021 Nov; 18(sup2):711-721. PubMed ID: 34570675
[TBL] [Abstract][Full Text] [Related]
13. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Wang A; Chen X; Li D; Yang L; Jiang J
J Clin Lab Anal; 2021 Sep; 35(9):e23931. PubMed ID: 34398984
[TBL] [Abstract][Full Text] [Related]
14. NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
Sun GF; Ding H
Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
[TBL] [Abstract][Full Text] [Related]
15. Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer.
Yuan Y; Fan Y; Tang W; Sun H; Sun J; Su H; Fan H
Sci Rep; 2024 Mar; 14(1):6270. PubMed ID: 38491127
[TBL] [Abstract][Full Text] [Related]
16. Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies.
Tan X; Cai Z; Chen G; Cai C; Chen J; Liang Y; Zhuo Y; Liu J; Huang L; Ouyang B; Wei Y; Jia Z; Deng J; Zhong W; Lu J
Discov Oncol; 2023 May; 14(1):62. PubMed ID: 37155024
[TBL] [Abstract][Full Text] [Related]
17. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
Pan Q; Yi C; Zhang Y
Front Oncol; 2022; 12():884377. PubMed ID: 35686101
[TBL] [Abstract][Full Text] [Related]
18. 5-Methylcytosine RNA Modifications Promote Retrovirus Replication in an ALYREF Reader Protein-Dependent Manner.
Eckwahl M; Xu R; Michalkiewicz J; Zhang W; Patel P; Cai Z; Pan T
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321818
[TBL] [Abstract][Full Text] [Related]
19. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m
Yang X; Yang Y; Sun BF; Chen YS; Xu JW; Lai WY; Li A; Wang X; Bhattarai DP; Xiao W; Sun HY; Zhu Q; Ma HL; Adhikari S; Sun M; Hao YJ; Zhang B; Huang CM; Huang N; Jiang GB; Zhao YL; Wang HL; Sun YP; Yang YG
Cell Res; 2017 May; 27(5):606-625. PubMed ID: 28418038
[TBL] [Abstract][Full Text] [Related]
20. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
Han L; Huang C; Zhang S
Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
